nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—Aripiprazole—CHRM2—type 1 diabetes mellitus	0.116	0.54	CrCbGaD
Vilazodone—Aripiprazole—ADRB1—type 1 diabetes mellitus	0.0985	0.46	CrCbGaD
Vilazodone—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00971	0.0576	CcSEcCtD
Vilazodone—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00928	0.055	CcSEcCtD
Vilazodone—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00864	0.0512	CcSEcCtD
Vilazodone—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00854	0.0506	CcSEcCtD
Vilazodone—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00778	0.0461	CcSEcCtD
Vilazodone—CYP2C18—FOXA1 transcription factor network—INS—type 1 diabetes mellitus	0.00704	0.0114	CbGpPWpGaD
Vilazodone—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00685	0.0406	CcSEcCtD
Vilazodone—CYP2D6—Melatonin metabolism and effects—ADRB1—type 1 diabetes mellitus	0.00667	0.0108	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—CHRM2—type 1 diabetes mellitus	0.00663	0.0107	CbGpPWpGaD
Vilazodone—SLC6A4—Monoamine Transport—IL1B—type 1 diabetes mellitus	0.00649	0.0105	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—PRF1—type 1 diabetes mellitus	0.00604	0.00978	CbGpPWpGaD
Vilazodone—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00585	0.0347	CcSEcCtD
Vilazodone—DRD2—Circadian rythm related genes—PAX4—type 1 diabetes mellitus	0.00547	0.00886	CbGpPWpGaD
Vilazodone—CYP2C18—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00528	0.00856	CbGpPWpGaD
Vilazodone—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00522	0.0309	CcSEcCtD
Vilazodone—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00518	0.0307	CcSEcCtD
Vilazodone—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00507	0.0301	CcSEcCtD
Vilazodone—Nervousness—Ramipril—type 1 diabetes mellitus	0.00503	0.0298	CcSEcCtD
Vilazodone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—type 1 diabetes mellitus	0.00492	0.00798	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.00489	0.00792	CbGpPWpGaD
Vilazodone—Tremor—Ramipril—type 1 diabetes mellitus	0.00486	0.0288	CcSEcCtD
Vilazodone—Agitation—Ramipril—type 1 diabetes mellitus	0.00476	0.0282	CcSEcCtD
Vilazodone—SLC6A4—Monoamine Transport—TNF—type 1 diabetes mellitus	0.00471	0.00763	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—CHRM2—type 1 diabetes mellitus	0.00462	0.00749	CbGpPWpGaD
Vilazodone—Palpitations—Ramipril—type 1 diabetes mellitus	0.00458	0.0272	CcSEcCtD
Vilazodone—Convulsion—Ramipril—type 1 diabetes mellitus	0.00449	0.0266	CcSEcCtD
Vilazodone—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00441	0.0262	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00438	0.026	CcSEcCtD
Vilazodone—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00431	0.0256	CcSEcCtD
Vilazodone—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00415	0.0246	CcSEcCtD
Vilazodone—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00411	0.0244	CcSEcCtD
Vilazodone—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00409	0.0242	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00385	0.0228	CcSEcCtD
Vilazodone—Insomnia—Ramipril—type 1 diabetes mellitus	0.00383	0.0227	CcSEcCtD
Vilazodone—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.0038	0.0225	CcSEcCtD
Vilazodone—Somnolence—Ramipril—type 1 diabetes mellitus	0.00376	0.0223	CcSEcCtD
Vilazodone—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00372	0.0221	CcSEcCtD
Vilazodone—DRD2—Circadian rythm related genes—PRF1—type 1 diabetes mellitus	0.00369	0.00598	CbGpPWpGaD
Vilazodone—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00368	0.0218	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00365	0.0217	CcSEcCtD
Vilazodone—Fatigue—Ramipril—type 1 diabetes mellitus	0.00365	0.0216	CcSEcCtD
Vilazodone—HTR1A—G alpha (i) signalling events—GAL—type 1 diabetes mellitus	0.00358	0.0058	CbGpPWpGaD
Vilazodone—HTR1A—G alpha (i) signalling events—CCL20—type 1 diabetes mellitus	0.00354	0.00574	CbGpPWpGaD
Vilazodone—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00349	0.0207	CcSEcCtD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.00348	0.00565	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.00341	0.00552	CbGpPWpGaD
Vilazodone—HTR1A—G alpha (i) signalling events—CHRM2—type 1 diabetes mellitus	0.00333	0.0054	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—GAL—type 1 diabetes mellitus	0.00314	0.0051	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—CCL20—type 1 diabetes mellitus	0.00311	0.00504	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.00309	0.00501	CbGpPWpGaD
Vilazodone—Asthenia—Ramipril—type 1 diabetes mellitus	0.00303	0.018	CcSEcCtD
Vilazodone—DRD2—G alpha (i) signalling events—CHRM2—type 1 diabetes mellitus	0.00292	0.00474	CbGpPWpGaD
Vilazodone—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00289	0.0172	CcSEcCtD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.00285	0.00461	CbGpPWpGaD
Vilazodone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.00283	0.00458	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00282	0.00456	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00282	0.00456	CbGpPWpGaD
Vilazodone—Dizziness—Ramipril—type 1 diabetes mellitus	0.0028	0.0166	CcSEcCtD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.00271	0.0044	CbGpPWpGaD
Vilazodone—Vomiting—Ramipril—type 1 diabetes mellitus	0.00269	0.0159	CcSEcCtD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00265	0.00429	CbGpPWpGaD
Vilazodone—Nausea—Ramipril—type 1 diabetes mellitus	0.00251	0.0149	CcSEcCtD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.0025	0.00405	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00247	0.00401	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00247	0.00401	CbGpPWpGaD
Vilazodone—HTR1A—G alpha (i) signalling events—SST—type 1 diabetes mellitus	0.00245	0.00398	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.00243	0.00393	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00232	0.00377	CbGpPWpGaD
Vilazodone—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.00229	0.0037	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00227	0.00367	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—CDK4—type 1 diabetes mellitus	0.00224	0.00364	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—NOS2—type 1 diabetes mellitus	0.00218	0.00353	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00217	0.00351	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—SST—type 1 diabetes mellitus	0.00216	0.00349	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00214	0.00347	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00214	0.00347	CbGpPWpGaD
Vilazodone—HTR1A—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.00204	0.0033	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00202	0.00327	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00199	0.00323	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00195	0.00316	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00194	0.00315	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.0019	0.00308	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00188	0.00305	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00188	0.00305	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.00183	0.00296	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.00182	0.00295	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—HBA2—type 1 diabetes mellitus	0.00181	0.00293	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00181	0.00292	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.00179	0.0029	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00177	0.00287	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00171	0.00278	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00171	0.00276	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—G6PC2—type 1 diabetes mellitus	0.0017	0.00275	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00169	0.00274	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00162	0.00263	CbGpPWpGaD
Vilazodone—HTR1A—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00158	0.00256	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00149	0.00241	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00149	0.00241	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00148	0.0024	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—ABCC8—type 1 diabetes mellitus	0.00147	0.00239	CbGpPWpGaD
Vilazodone—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00147	0.00238	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00142	0.00231	CbGpPWpGaD
Vilazodone—DRD2—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00139	0.00225	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—CDK4—type 1 diabetes mellitus	0.00137	0.00222	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—NOS2—type 1 diabetes mellitus	0.00133	0.00216	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.00133	0.00215	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00132	0.00215	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00131	0.00211	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.0013	0.00211	CbGpPWpGaD
Vilazodone—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00129	0.00209	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.00127	0.00206	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.00127	0.00206	CbGpPWpGaD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00126	0.00204	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00124	0.002	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00123	0.00199	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00121	0.00196	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.00118	0.00191	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00117	0.00189	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00116	0.00188	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00114	0.00185	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00111	0.0018	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.0011	0.00179	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.0011	0.00178	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.0011	0.00178	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00108	0.00176	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00108	0.00174	CbGpPWpGaD
Vilazodone—SLC6A4—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.00107	0.00173	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00106	0.00172	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00103	0.00168	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00102	0.00166	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.001	0.00162	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—ITPR3—type 1 diabetes mellitus	0.000984	0.00159	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.000977	0.00158	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.000966	0.00157	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.000966	0.00157	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000958	0.00155	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000957	0.00155	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000929	0.0015	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—HBA1—type 1 diabetes mellitus	0.000926	0.0015	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.000924	0.0015	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—APOC3—type 1 diabetes mellitus	0.00092	0.00149	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.000908	0.00147	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GSTT1—type 1 diabetes mellitus	0.000903	0.00146	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000898	0.00146	CbGpPWpGaD
Vilazodone—SLC6A4—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000874	0.00142	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000869	0.00141	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000841	0.00136	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00084	0.00136	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00084	0.00136	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000836	0.00135	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000816	0.00132	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000763	0.00124	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000763	0.00124	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000759	0.00123	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000749	0.00121	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000746	0.00121	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000737	0.00119	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000734	0.00119	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000721	0.00117	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GCG—type 1 diabetes mellitus	0.00072	0.00117	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.0007	0.00113	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000698	0.00113	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00068	0.0011	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00067	0.00109	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000667	0.00108	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000657	0.00107	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000657	0.00106	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000654	0.00106	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00065	0.00105	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00065	0.00105	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000636	0.00103	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000634	0.00103	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000633	0.00103	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	0.000618	0.001	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000615	0.000996	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000613	0.000993	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000611	0.00099	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CAT—type 1 diabetes mellitus	0.000609	0.000987	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000597	0.000967	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	0.000581	0.000941	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000577	0.000935	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000575	0.000931	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000571	0.000925	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000571	0.000925	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000558	0.000904	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000556	0.000902	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000549	0.000889	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000541	0.000877	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000537	0.000869	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000535	0.000866	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000533	0.000864	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000516	0.000837	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000513	0.000832	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000513	0.000832	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	0.000504	0.000816	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000492	0.000796	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000484	0.000785	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000482	0.000781	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000475	0.00077	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000468	0.000759	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000453	0.000735	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000451	0.00073	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000451	0.00073	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000451	0.00073	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000449	0.000727	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000432	0.000699	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000425	0.000689	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—INS—type 1 diabetes mellitus	0.000404	0.000655	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	0.000404	0.000655	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000402	0.000651	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000398	0.000645	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SST—type 1 diabetes mellitus	0.000396	0.000641	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000394	0.000638	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000387	0.000626	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	0.00038	0.000615	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000375	0.000608	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000374	0.000607	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—ALB—type 1 diabetes mellitus	0.000371	0.000601	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—NOS3—type 1 diabetes mellitus	0.000355	0.000575	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000353	0.000571	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000341	0.000553	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00034	0.000551	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000339	0.00055	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	0.000336	0.000545	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.00033	0.000534	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	0.000329	0.000534	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000329	0.000533	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000327	0.00053	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	0.000316	0.000512	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	0.000314	0.000509	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000313	0.000507	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000311	0.000503	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	0.000309	0.0005	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.0003	0.000486	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000299	0.000484	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000295	0.000478	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.00029	0.00047	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000287	0.000466	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000286	0.000464	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000284	0.00046	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000275	0.000445	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000273	0.000442	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00026	0.000422	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000259	0.00042	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000255	0.000413	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000251	0.000407	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000249	0.000404	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	0.000246	0.000399	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000239	0.000387	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000226	0.000366	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	0.00022	0.000356	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000218	0.000354	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000217	0.000352	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	0.00021	0.00034	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	0.000208	0.000337	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	0.000207	0.000335	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	0.000206	0.000333	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	0.000202	0.000327	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000202	0.000327	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	0.000198	0.000321	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000198	0.000321	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000192	0.000311	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000191	0.000309	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000177	0.000287	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000174	0.000282	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000168	0.000272	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000168	0.000272	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000167	0.00027	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	0.000161	0.000261	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000148	0.000239	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000147	0.000239	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000147	0.000237	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000141	0.000229	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	0.000138	0.000224	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	0.000136	0.000221	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000128	0.000208	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	0.000127	0.000205	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000124	0.000201	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	0.000121	0.000196	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000113	0.000183	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	9.86e-05	0.00016	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	9.04e-05	0.000146	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	8.66e-05	0.00014	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	8.29e-05	0.000134	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	7.93e-05	0.000128	CbGpPWpGaD
